Pennant Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-65,000
Closed -$9.14M 22
2020
Q2
$9.14M Sell
65,000
-74,000
-53% -$10.8M 3.86% 12
2020
Q1
$18.2M Buy
139,000
+54,000
+64% +$7.66M 6.56% 6
2019
Q4
$12.4M Buy
85,000
+15,000
+21% +$2.03M 4.43% 14
2019
Q3
$9.06M Buy
+70,000
New +$9.22M 3.19% 14

Other funds holding JNJ

Pennant Investors's JNJ Position: Q3 2020 in Review

Pennant Investors sold out of Johnson & Johnson (JNJ) in Q3 2020, closing a stake of 65,000 shares — an estimated $9.14M sold.

Pennant Investors first reported a position in JNJ in Q3 2019 and held it in 4 quarters. The position peaked at $18.2M in Q1 2020. 2,985 funds tracked by Wall St. Rank hold JNJ as of Q3 2020.

  • Pennant Investors reported no remaining Johnson & Johnson position as of Q3 2020 after selling out during the quarter.
  • Pennant Investors sold 65,000 Johnson & Johnson shares in Q3 2020, an estimated $9.14M.
  • Pennant Investors first reported a position in Johnson & Johnson in Q3 2019 and held it in 4 quarters.
  • Pennant Investors's Johnson & Johnson position peaked at $18.2M in Q1 2020.
  • 2,985 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2020.

Based on Pennant Investors's 13F filing for Q3 2020, filed 16 Nov 2020.